OPTIO RX

Serial Number 87868059
606

Registration Progress

Application Filed
Apr 9, 2018
Under Examination
Nov 27, 2018
Approved for Publication
Oct 2, 2018
Published for Opposition
Oct 2, 2018
Registered

Trademark Image

OPTIO RX

Basic Information

Serial Number
87868059
Filing Date
April 9, 2018
Published for Opposition
October 2, 2018
Abandonment Date
December 30, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 30, 2019
Classes
005 035 040 042

Rights Holder

Optio Rx, LLC

16
Address
Suite 200
1247 Waukegan Rd.
Glenview, IL 60025

Ownership History

Optio Rx, LLC

Original Applicant
16
Glenview, IL

Optio Rx, LLC

Owner at Publication
16
Glenview, IL

Legal Representation

Attorney
Michael J. Femal

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description Documents
Dec 30, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 30, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 30, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 28, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 28, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
May 28, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 2, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 2, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 12, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 23, 2018 ALIE A ASSIGNED TO LIE Loading...
Aug 14, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 3, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 3, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 3, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 3, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 27, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 17, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 12, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antiallergic medicines; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
First Use Anywhere: 0
First Use in Commerce: 0
Class 035
Providing an on-line searchable database featuring referrals in the field of Medicine; Providing an on-line searchable database featuring referrals in the field of human and animal drug therapy; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Supplying prescription drugs to health plan participants for the funding organizations
First Use Anywhere: 0
First Use in Commerce: 0
Class 040
Custom manufacture of drugs to save lives by pharmaceutical compounders; Custom manufacture of drugs for cardiovascular therapy by pharmaceutical compounders; Custom manufacture of medicines by pharmaceutical compounders; Custom manufacture of human and animal pharmaceuticals by pharmaceutical compounders
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Development of pharmaceutical preparations and medicines; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Research and development of vaccines and medicines; Scientific study and research in the field of medicines; Scientific study and research in the field of drugs and medicines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 035 040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"RX"